Brand Awareness Campaign
Vimovo® is a prescription only medicine (POM) used for the relief of symptoms of chronic progressive inflammatory diseases, such as osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. W was asked to develop a brand awareness campaign for Vimovo®, including print and digital deliverables aimed at hospital-based specialists and General Practitioners based in Norway.
Once all the channels had been identified, both print and web, a phased timeline for implementing the Vimovo® brand awareness campaign was developed. Since print had the largest audience, W recommended that Grünenthal initially place the Vimovo® ad in the journals with the largest subscription base: Dagens Medisin and Tidsskriftet. Using these advertisements for inspiration, W also created a number of website banners, that were also placed on websites most visited by target HCPs, thereby further increasing the brand’s share of voice in Norway.
We chose W for several reasons! We saw the opportunity to create a strong strategic cooperation with W and that they had the ability to deliver according to our objectives, timelines and needs. W was also able to offer good project management in a way that matched our need for good cross-functional working. We look forward to continuing to develop our collaboration with W on new projects.
Want to know more? Contact Account Director Sunil Ramkali.
Get news and inspiration from W straight to your inbox! Sign up for Whispers, our quarterly newsletter, right here: